ZOLL MEDICAL CORP Research and Development Expense
ZOLL MEDICAL CORP reported Research and Development Expense of $10.96 million for the 3-month period ending 2012-01-01, per its 10-Q filed 2012-02-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2012-02-02
- ZOLL MEDICAL CORP research and development expense for the quarter ending 2012-01-01 was $10.96M, a 1.15% increase year-over-year.
- ZOLL MEDICAL CORP research and development expense for the quarter ending 2011-10-02 was $10.75M, a 8.18% decline year-over-year.
- ZOLL MEDICAL CORP research and development expense for the quarter ending 2011-07-03 was $11.68M, a 0.92% increase year-over-year.
- ZOLL MEDICAL CORP research and development expense for the quarter ending 2011-01-02 was $10.84M.
- ZOLL MEDICAL CORP research and development expense for fiscal 2011 was $44.36M, a 3.42% decline from fiscal 2010.
- ZOLL MEDICAL CORP research and development expense for fiscal 2010 was $45.93M, a 16.36% increase from fiscal 2009.
- ZOLL MEDICAL CORP research and development expense for fiscal 2009 was $39.47M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2012-01-01 | $10.96M 10-Q · filed 2012-02-02 | $21.71M derived: sum of 2 quarters · filed 2012-02-02 | $33.39M derived: sum of 3 quarters · filed 2012-02-02 | |
| 2011-10-02 | $10.75M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2011-12-01 | $22.42M derived: sum of 2 quarters · filed 2011-12-01 | $44.36M 10-K/A · filed 2011-12-01 | |
| 2011-07-03 | $11.68M 10-Q/A · filed 2011-08-24 | $33.61M 10-Q/A · filed 2011-08-24 | ||
| 2011-01-02 | $10.84M 10-Q · filed 2012-02-02 | $22.54M derived: sum of 2 quarters · filed 2012-02-02 | $34.11M derived: sum of 3 quarters · filed 2012-02-02 | |
| 2010-10-03 | $11.71M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2011-12-01 | $23.28M derived: sum of 2 quarters · filed 2011-12-01 | $45.93M 10-K/A · filed 2011-12-01 | |
| 2010-07-04 | $11.57M 10-Q/A · filed 2011-08-24 | $34.23M 10-Q/A · filed 2011-08-24 | ||
| 2009-09-27 | $39.47M 10-K/A · filed 2011-12-01 |